Open an account

Medite Cancer Diagnostics

MDIT · OTC

$0.0001+$0.0001 (+0.00%)TodayMarket closed ·
No price history for this range.

About MDIT

MEDITE Cancer Diagnostics, Inc. is a medical technology company which engages in cancer diagnostics instruments and consumables for histology and cytology laboratories. The company is headquartered in Chicago, Illinois. The firm also develops, manufactures, markets, and sells MEDITE branded products (instruments and consumables), in the areas of histology and cytology. The firm has a distribution network to over 80 countries and a range of products for anatomic pathology, histology and cytology laboratories available for sale. The Company’s subsidiaries consist of MEDITE Enterprise, Inc., MEDITE GmbH, Burgdorf, Germany and MEDITE Lab Solutions Inc.

Employees
0
Headquarters
Chicago, Illinois
Listed
Oct 27, 1993
Sector
Health Care
Industry
Health Care Equipment & Supplies
Website
medite-group.com

MDIT key statistics

Market cap
8.62K
Price-earnings ratio
—
Dividend yield
—
Average volume
200
Volume
2.03K
Open price
$0.0001
High today
$0.0001
Low today
$0.0001
52 Week high
$0.0001
52 Week low
$0.0001

Medite Cancer Diagnostics (MDIT) at a glance

As of Oct 5, 2026, Medite Cancer Diagnostics (MDIT) shares are priced at $0.0001, giving the company a market cap of 8.62K.

Volume so far is 2.03K shares, above the average of 200 shares a day.

Similar companies

Companies in the same industry as Medite Cancer Diagnostics

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.